Literature DB >> 33751565

Chronic restraint stress promotes the mobilization and recruitment of myeloid-derived suppressor cells through β-adrenergic-activated CXCL5-CXCR2-Erk signaling cascades.

Mingyue Cao1, Wei Huang1, Yuzhu Chen1, Gaoxiang Li2, Nasi Liu1, Youming Wu1, Guiping Wang2, Qian Li2, Dexin Kong1, Tongtong Xue1, Nan Yang1, Yanyong Liu1,2.   

Abstract

Myeloid-derived suppressor cells (MDSCs) play an important role in tumor immune escape. Recent studies have shown that MDSCs contribute to tumor progression under psychological stress, but the underlying mechanism of MDSCs mobilization and recruitment remains largely unknown. In the present study, a chronic restraint stress paradigm was applied to the H22 hepatocellular carcinoma (HCC) bearing mice to mimic the psychological stress. We observed that chronic restraint stress significantly promoted HCC growth, as well as the mobilization of MDSCs to spleen and tumor sites from bone marrow. Meanwhile, chronic restraint stress enhanced the expression of C-X-C motif chemokine receptor 2 (CXCR2) and pErk1/2 in bone marrow MDSCs, together with elevated chemokine (C-X-C motif) ligand 5 (CXCL5) expression in tumor tissues. In vitro, the treatments of MDSCs with epinephrine (EPI) and norepinephrine (NE) but not corticosterone (CORT)-treated H22 conditioned medium obviously inhibited T-cell proliferation, as well as enhanced CXCR2 expression and extracellular signal-regulated kinase (Erk) phosphorylation. In vivo, β-adrenergic blockade with propranolol almost completely reversed the accelerated tumor growth induced by chronic restraint stress and inactivated CXCL5-CXCR2-Erk signaling pathway. Our findings support the crucial role of β-adrenergic signaling cascade in the mobilization and recruitment of MDSCs under chronic restraint stress.
© 2021 UICC.

Entities:  

Keywords:  CXCL5-CXCR2; Erk; chronic restraint stress; myeloid-derived suppressor cells (MDSCs); β-adrenergic receptor

Year:  2021        PMID: 33751565     DOI: 10.1002/ijc.33552

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity.

Authors:  Wei Li; Jielin Wan; Cuiyu Chen; Chengfang Zhou; Ping Liao; Qian Hu; Jiali Hu; Yang Wang; Yu Zhang; Cong Peng; Yuanfei Huang; Weihua Huang; Wei Zhang; Howard L Mcleod; Yijing He
Journal:  J Mol Med (Berl)       Date:  2022-07-27       Impact factor: 5.606

2.  Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling.

Authors:  Jiale An; Lifeng Feng; Jiling Ren; Yafei Li; Guangru Li; Chang Liu; Yong Yao; Ye Yao; Zecheng Jiang; Yang Gao; Yang Xu; Yachen Wang; Jing Li; Jie Liu; Lei Cao; Zhi Qi; Liang Yang
Journal:  Oncoimmunology       Date:  2021-11-23       Impact factor: 8.110

3.  The dynamic changes of cellular immunity among frontline medical workers who supported Wuhan for fighting against the COVID-19.

Authors:  Juanjuan Yang; Qian Wang; Shuqun Zhang; Zongfang Li; Wei Jiang
Journal:  Int Immunopharmacol       Date:  2021-11-23       Impact factor: 4.932

Review 4.  Impact of Lipid Metabolism on Antitumor Immune Response.

Authors:  Nesrine Mabrouk; Baptiste Lecoeur; Ali Bettaieb; Catherine Paul; Frédérique Végran
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

Review 5.  Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor.

Authors:  Si-Qing Liu; Bei Li; Juan-Juan Li; Si Sun; Sheng-Rong Sun; Qi Wu
Journal:  Front Cell Dev Biol       Date:  2022-08-22

6.  Shumian Capsule Improves the Sleep Disorder and Mental Symptoms Through Melatonin Receptors in Sleep-Deprived Mice.

Authors:  Wenhua Li; Yinlong Cheng; Yi Zhang; Yazhi Qian; Mo Wu; Wei Huang; Nan Yang; Yanyong Liu
Journal:  Front Pharmacol       Date:  2022-07-08       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.